cas 23945-44-0|| where to buy 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid

Nom du produit:2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid

IUPAC Name:2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM104193-100g	in stock	ǜȡ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 23945-44-0 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:23945-44-0; Formule moléculaire:C5H4N2O4; Point de fusion:-; Code SMILES:OC(=O)C1=CNC(=O)NC1=O; Densité:

: Numéro de catalogue:CM104193; Poids moléculaire:156.1; Point d'ébullition:; N° Mdl:MFCD00075737; Stockage:

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

: Cerdulatinib; Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK. Cerdulatinib is a reversible ATP-competitive dual JAK and Syk inhibitor. The FDA granted orphan drug status to cerdulatinib for the treatment of peripheral T-cell lymphoma (PTCL).